Source: Annual Congress 2010 - Scientific Year in Review



Rating:

Share or cite this content

Citations should be made in the following way:
C. Dean (Oxfordshire, United Kingdom). N-ethyl-N-nitrosourea mutagenesis: a new tool for exploring lung disease. Annual Congress 2010 - Scientific Year in Review

Member's Comments

No comment yet.

Related content which might interest you: Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis? Source: Eur Respir J 2016; 48: 1271-1273 Year: 2016 Interference RNA as a new tool and possible future therapy for inflammatory lung disease Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005 Genetic studies as a tool for identifying novel potential targets for treatment of COPD Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017 Year: 2017 COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications Source: Eur Respir J 2009; 33: 489-506 Year: 2009 HOPE-BAL: A novel tool to expand the methodological capabilities in pulmonary research Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Utilising data from single cell approaches to study existing and recently emerging lung diseases? Source: Virtual Congress 2021 – Utilising data from single cell approaches to study existing and recently emerging lung diseases? Year: 2021 Applying new respiratory function technologies to the elderly and the potential of future lung regeneration Source: Virtual Congress 2020 – Lung health and respiratory function at all ages Year: 2020 Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Phospholipids qualitative analysis: A new diagnostic tool to characterize ABCA3-Associated disease and guide genetic analysis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Biomarkers for fibrotic lung disease - new clinical benchmarks from the lab? Source: Annual Congress 2013 –ME3 Biomarkers for fibrotic lung disease – new clinical benchmarks from the lab? Year: 2013 Developing a novel in vitro 3D airway model to provide a viable alternative to animal use in asthma research Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 Interstitial lung disease: new challenges and evolving phenotypes Source: Eur Respir Rev 2009; 19: 91-93 Year: 2010 Evaluating COPD disease management: application of a theoretical model Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Development of an integrative approach to identify key molecular targets involved in bleomycin-induced pulmonary fibrosis in rats. Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017